NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Curigin Co., Ltd.

Curigin Co., Ltd.

Private
SeoulHealthcare & Life Scienceshttp://curigin.com/

Last Round

VC Round

Apr 1, 2021

Est. Valuation

$59.64M

Total Funding Raised

$6.06M

Company Overview

Curigin Co., Ltd. is a biotechnology company that develops oncolytic virus-based gene therapies for treating cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

oncolytic gene therapyRNAi therapyoncolytic virusoncolytic virotherapygene silencingbi-specific shRNAengineered adenovirusdual-target therapyviral capsid engineeringRNA interferenceRNAigene therapy platformgene knockdownpancreatic cancerbladder cancerviral vector

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Curigin Co., Ltd. Comparables

Compare Curigin Co., Ltd. with similar companies based on industry and business-model similarity.

Curigin Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Curigin Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 1, 2021
Series AMay 1, 2019
SeedMar 1, 2018

Curigin Co., Ltd. Investors

Notable investors and investment history

Curigin Co., Ltd. investors
InvestorRounds
DSC InvestmentSeries A, Seed
Timefolio Asset ManagementVC Round
Company K PartnersVC Round
Korea Investment PartnersSeries A, Seed
SchmidtSeries A
Hana SecuritiesVC Round
LB InvestmentVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    Monthly visitors increased 2049% MoM, reaching 2.7K.

  • May 4, 2025

    Monthly visitors grew 72% MoM, from 757 to 1.3K.

Curigin Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Curigin Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Curigin Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range7
Year Founded2016
Last FundingApr 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.